{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:56:11Z","timestamp":1791410171228,"version":"4.3.3"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ejpb.2021.02.014","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T03:33:52Z","timestamp":1616556832000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Highly cross-linked arabinoxylans microspheres as a microbiota-activated carrier for colon-specific insulin delivery"],"prefix":"10.1016","volume":"163","author":[{"given":"A.M.","family":"Morales-Burgos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Carvajal-Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sotelo-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rasc\u00f3n-Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lizardi-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.L.","family":"L\u00f3pez-Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Mart\u00ednez-Porchas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Canett-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpb.2021.02.014_b0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2012.03.056","article-title":"Oral delivery of therapeutic protein\/peptide for diabetes \u2013 Future perspectives","volume":"440","author":"Rekha","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.02.014_b0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jphp.12852","article-title":"Oral insulin delivery: existing barriers and current counter-strategies","volume":"70","author":"Gedawy","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.014_b0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s001250050081","article-title":"Biochemical and morpho-cytochemical evidence for the intestinal absorption of insulin in control and diabetic rats. Comparison between the effectiveness of duodenal and colon mucosa","volume":"37","author":"Bendayan","year":"1994","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.ejpb.2021.02.014_b0020","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/j.1745-7254.2006.00424.x","article-title":"In vitro and in vivo evaluation of a novel oral insulin formulation","volume":"27","author":"Ma","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.014_b0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0144-8617(95)00077-1","article-title":"Cereal arabinoxylans: advances in structure and physicochemical properties","volume":"28","author":"Izydorczyk","year":"1995","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2021.02.014_b0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/bm049629a","article-title":"Arabinoxylan gels: impact of the feruloylation degree on their structure and properties","volume":"6","author":"Carvajal-Millan","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2021.02.014_b0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.carbpol.2016.02.031","article-title":"In vitro degradation of covalently cross-linked arabinoxylan hydrogels by bifidobacteria","volume":"144","author":"Mart\u00ednez-L\u00f3pez","year":"2016","journal-title":"Carbohydr. Polym."},{"issue":"11","key":"10.1016\/j.ejpb.2021.02.014_b0040","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1128\/AEM.69.11.6354-6360.2003","article-title":"Degradation of cross-linked and non-cross-linked arabinoxylans by the intestinal microbiota in children","volume":"69","author":"Hopkins","year":"2003","journal-title":"Appl. Environ. Microbiol."},{"issue":"1-2","key":"10.1016\/j.ejpb.2021.02.014_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(02)00004-2","article-title":"Colon-specific drug delivery: new approaches and in vitro\/in vivo evaluation","volume":"235","author":"Yang","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2021.02.014_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020944","article-title":"Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides\/Prevotella in Diet-Induced Obese Mice","volume":"6","author":"Neyrinck","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2021.02.014_b0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.carbpol.2015.11.068","article-title":"Arabinoxylans, gut microbiota and immunity","volume":"139","author":"Mendis","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2021.02.014_b0060","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ijbiomac.2018.12.192","article-title":"Enzymatically cross-linked arabinoxylan microspheres as oral insulin delivery system","volume":"126","author":"Mart\u00ednez-L\u00f3pez","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"38","key":"10.1016\/j.ejpb.2021.02.014_b0065","doi-asserted-by":"crossref","first-page":"47960","DOI":"10.1002\/app.47960","article-title":"Tailoring reversible insulin aggregates loaded in electrosprayed arabinoxylan microspheres intended for colon-targeted delivery","volume":"136","author":"Morales\u2010Burgos","year":"2019","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.ejpb.2021.02.014_b0070","unstructured":"Secretar\u00eda de Agricultura, Ganader\u00eda, Desarrollo Rural, Pesca y Alimentaci\u00f3n., Norma Oficial Mexicana NOM-062-ZOO-1999, Especificaciones Tecnicas Para La Produccion, Cuidado Y Uso De Los Animales De Laboratorio., n.d. https:\/\/www.gob.mx\/senasica\/documentos\/nom-062-zoo-1999 (accessed January 4, 2019)."},{"key":"10.1016\/j.ejpb.2021.02.014_b0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4067\/S0717-95022018000100206","article-title":"Effects on alveolar bone of diabetes mellitus induced by streptozotocin in rats. Histopathologic and immunohistochemical study","volume":"36","author":"Yilmaz","year":"2018","journal-title":"Int. J. Morphol."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2021.02.014_b0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"12","key":"10.1016\/j.ejpb.2021.02.014_b0085","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1002\/jps.21347","article-title":"Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response","volume":"97","author":"Reis","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ejpb.2021.02.014_b0090","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/bmc.580","article-title":"Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography","volume":"20","author":"Zhao","year":"2006","journal-title":"Biomed. Chromatogr."},{"issue":"5","key":"10.1016\/j.ejpb.2021.02.014_b0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat. Methods"},{"issue":"7","key":"10.1016\/j.ejpb.2021.02.014_b0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: High-resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejpb.2021.02.014_b0105","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gks1219","article-title":"The SILVA ribosomal RNA gene database project: improved data processing and web-based tools","volume":"41","author":"Quast","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejpb.2021.02.014_b0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/01480545.2014.956219","article-title":"Acute toxicity studies of a novel excipient arabinoxylan isolated from Ispaghula (Plantago ovata) husk","volume":"38","author":"Erum","year":"2015","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.ejpb.2021.02.014_b0115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/medicina55070349","article-title":"Arabinoxylan-based particles. In vitro antioxidant capacity and cytotoxicity on a human colon cell line","volume":"55","author":"Mendez-Encinas","year":"2019","journal-title":"Medicina (Mex.)"},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.014_b0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/09637486.2019.1610729","article-title":"Arabinoxylans and gelled arabinoxylans used as anti-obesogenic agents could protect the stability of intestinal microbiota of rats consuming high-fat diets","volume":"71","author":"Carvajal-Millan","year":"2020","journal-title":"Int. J. Food Sci. Nutr."},{"key":"10.1016\/j.ejpb.2021.02.014_b0125","first-page":"54","article-title":"Streptozotocin-induced experimental diabetes in male Wistar rats","volume":"18","author":"Gajdos\u00edk","year":"1999","journal-title":"Gen. Physiol. Biophys."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.014_b0130","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2009.01.011","article-title":"Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption","volume":"135","author":"Rekha","year":"2009","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.014_b0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/03639045.2017.1386197","article-title":"Microspheres for the oral delivery of insulin: preparation, evaluation and hypoglycaemic effect in streptozotocin-induced diabetic rats","volume":"44","author":"Zhang","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2021.02.014_b0140","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1099\/mic.0.082610-0","article-title":"Streptozotocin-induced type-1-diabetes disease onset in Sprague-Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity","volume":"161","author":"Patterson","year":"2015","journal-title":"Microbiology"},{"issue":"5728","key":"10.1016\/j.ejpb.2021.02.014_b0145","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the Human Intestinal Microbial Flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:41:37Z","timestamp":1760546497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":29,"alternative-id":["S0939641121000758"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.02.014","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly cross-linked arabinoxylans microspheres as a microbiota-activated carrier for colon-specific insulin delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}